Literature DB >> 8976707

Thyroid eye disease.

D H Char1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8976707      PMCID： PMC505652          DOI： 10.1136/bjo.80.10.922

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  73 in total

1.  Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.

Authors:  E P Pequegnat; W E Mayberry; W M McConahey; E P Wyse
Journal:  Mayo Clin Proc       Date:  1967-12       Impact factor: 7.616

2.  Medical approach to ophthalmopathy of Graves' disease.

Authors:  H K Ivy
Journal:  Mayo Clin Proc       Date:  1972-12       Impact factor: 7.616

Review 3.  Pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

4.  Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists.

Authors:  A E Heufelder; R S Bahn
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

5.  Early complications of radioiodine treatment for hyperthyroidism.

Authors:  O Segers; W Musch; D F Schoors
Journal:  Acta Clin Belg       Date:  1993       Impact factor: 1.264

6.  Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics.

Authors:  R Elisei; D Weightman; P Kendall-Taylor; G Vassart; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

Review 7.  Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.

Authors:  D R Ciocca; S Oesterreich; G C Chamness; W L McGuire; S A Fuqua
Journal:  J Natl Cancer Inst       Date:  1993-10-06       Impact factor: 13.506

8.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.

Authors:  L Bartalena; C Marcocci; L Chiovato; M Laddaga; G Lepri; D Andreani; G Cavallacci; L Baschieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

9.  Endocrine ophthalmomyopathy in adolescence.

Authors:  H S Metz; P D Woolf; M L Patton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1982 Jan-Feb       Impact factor: 1.402

10.  Dysthyroid ophthalmopathy in children.

Authors:  L A Young
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1979 Mar-Apr       Impact factor: 1.402
View more
  4 in total

1.  T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy.

Authors:  A Pappa; J M Lawson; V Calder; P Fells; S Lightman
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 2.  The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.

Authors:  Yang Wang; Huifang Zhou; Xianqun Fan
Journal:  Front Med       Date:  2017-05-13       Impact factor: 4.592

3.  Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy.

Authors:  Kai-Chun Cheng; Han-Hsiang Huang; Chun-Tzu Hung; Cheng-Chi Chen; Wen-Chuan Wu; Jau-Ling Suen; Kuo-Jen Chen; Yu-Jen Wu; Cheng-Hsien Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-28       Impact factor: 3.117

4.  Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center.

Authors:  Gholamreza Khataminia; Farshad Ostadian; Mohammad Noroozzadeh; Mahmoud Latifi; Masoud Khataminia
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.